Status:
COMPLETED
Treatment of Acute Myeloblastic Leukemia in Younger Patients
Lead Sponsor:
PETHEMA Foundation
Conditions:
Acute Myeloblastic Leukemia
Eligibility:
All Genders
Up to 65 years
Brief Summary
study of the value of the cytogenetics and the monitoring of the residual minimum disease in the standard treatment of acute myeloblastic leukemia.
Detailed Description
The treatment scheme is purely welfare and therefore it does not require any approval of ethical committees for his application. It gathers the basic ideas of the present treatment of the AML, with op...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age\< or =65 years.
- ECOG\<=3.
- AML of new diagnose.
- Consent for chemotherapy.
Exclusion
Key Trial Info
Start Date :
January 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00390715
Start Date
January 1 1999
End Date
January 1 2010
Last Update
March 15 2010
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General de Alicante
Alicante, Alicante, Spain
2
Hospital Clínic
Barcelona, Barcelona, Spain
3
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, Spain
4
Hospital del Mar
Barcelona, Barcelona, Spain